The efficacy and safety of monoclonal antibody therapies for interstitial cystitis/bladder pain syndrome: A meta‐analysis of randomized controlled trials

Documenti analoghi

• Multi‐omics analyses uncover metabolic signatures and gene expression profiles of interstitial cystitis/bladder pain syndrome
  di: Xianyanling Yi, et al.
  Pubblicazione: (2024)
• Extracorporeal shockwave therapy in treatment of chronic prostatitis/chronic pelvic pain syndrome: Systematic review and meta‐analyses
  di: Ivan Labetov, et al.
  Pubblicazione: (2024)
• Fragility of overactive bladder medication clinical trials: A systematic review
  di: Kevin D. Li, et al.
  Pubblicazione: (2024)
• Efficacy and safety of onabotulinumtoxinA for the treatment of overactive bladder in men and women: A pooled analysis
  di: Victor W. Nitti, et al.
  Pubblicazione: (2024)
• The rationale for bladder washouts in children with neurogenic bladder
  di: Gopal‐Krsna Singh, et al.
  Pubblicazione: (2024)